Celgene (CELG) Tops Q2 EPS by 5c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Celgene Reports Second Quarter 2018 Operating and Financial Results
July 26, 2018 7:30 AM EDTStrong total net product sales of $3.8 billion, increased 17% Y/Y
Raising full-year total revenue guidance to ~$15 billion and REVLIMID® net sales to ~$9.7 billion
Advancing late-stage next-generation growth drivers
SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported net product sales of $3,808 million for the second quarter of 2018, a 17 percent increase from the same period in 2017. Celgene reported second quarter 2018 total revenue of $3,814 million, a 17 percent increase compared to $3,271 million in the second quarter of 2017.
Based on U.S. GAAP... More



